Get startedLog in
    Picture of Kalvista Pharmaceuticals logo

    KALV — Kalvista Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    US FDA approves KalVista Pharma's swelling disorder drug

    Picture of Kalvista Pharmaceuticals logoKalvista Pharmaceuticals
    07/07/2025 11:33
    July 7 (Reuters) - The U.S. Food and Drug Administration approved KalVista Pharmaceuticals' KALV.O drug for a type of hereditary swelling disorder, the company said on Monday.

 (Reporting by Puyaan Singh in Bengaluru; Editing by Arun Koyyur)

 ((Puyaan.Singh@thomsonreuters.com;))

    Recent news on Kalvista Pharmaceuticals

    See all news